Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03771066 · ClinicalTrials.gov registry record · NA
Bisphenol A and Muscle Insulin Sensitivity
A NA study, sponsored by California Polytechnic State University-San Luis Obispo.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03771066 is a NA study that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 40 participants.
The verdict
NCT03771066, a NA study, has completed, sponsored by California Polytechnic State University-San Luis Obispo.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.
Interventions
- BEHAVIORAL Placebo
- BEHAVIORAL bisphenol A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03771066
The ClinicalTrials.gov registry entry for NCT03771066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California Polytechnic State University-San Luis Obispo, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03771066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03771066 about?
NCT03771066 is a clinical study titled "Bisphenol A and Muscle Insulin Sensitivity". This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.
What is the current status of trial NCT03771066?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-01-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03771066?
The interventions under investigation include: Placebo (BEHAVIORAL), bisphenol A (BEHAVIORAL).
Who is sponsoring clinical trial NCT03771066?
This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.